Windtree Therapeutics Inc (WINT)
3.571
-0.07
(-1.90%)
USD |
NASDAQ |
May 31, 16:00
3.57
0.00 (0.00%)
After-Hours: 20:00
Windtree Therapeutics Cash from Financing (Quarterly): 1.034M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.034M |
December 31, 2023 | 0.521M |
September 30, 2023 | -0.233M |
June 30, 2023 | 10.72M |
March 31, 2023 | 0.591M |
December 31, 2022 | 1.116M |
September 30, 2022 | 1.157M |
June 30, 2022 | 0.895M |
March 31, 2022 | -0.089M |
December 31, 2021 | 2.912M |
September 30, 2021 | -0.04M |
June 30, 2021 | -1.119M |
March 31, 2021 | 27.61M |
December 31, 2020 | 0.048M |
September 30, 2020 | -1.137M |
June 30, 2020 | 21.25M |
March 31, 2020 | -0.199M |
December 31, 2019 | 22.74M |
September 30, 2019 | -0.346M |
June 30, 2019 | -0.027M |
March 31, 2019 | -0.598M |
December 31, 2018 | 30.42M |
September 30, 2018 | 3.28M |
June 30, 2018 | 2.541M |
March 31, 2018 | 2.50M |
Date | Value |
---|---|
December 31, 2017 | 4.871M |
September 30, 2017 | 2.60M |
June 30, 2017 | 0.039M |
March 31, 2017 | 9.786M |
December 31, 2016 | 0.238M |
September 30, 2016 | 0.402M |
June 30, 2016 | 0.069M |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 27.74M |
June 30, 2015 | -0.021M |
March 31, 2015 | -0.02M |
December 31, 2014 | -0.021M |
September 30, 2014 | -0.017M |
June 30, 2014 | -0.02M |
March 31, 2014 | 0.435M |
December 31, 2013 | 75.54M |
September 30, 2013 | -0.015M |
June 30, 2013 | 15.09M |
March 31, 2013 | 9.833M |
December 31, 2012 | -0.066M |
September 30, 2012 | -0.018M |
June 30, 2012 | 0.01M |
March 31, 2012 | 50.30M |
December 31, 2011 | 0.32M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.137M
Minimum
Sep 2020
27.61M
Maximum
Mar 2021
4.370M
Average
0.556M
Median
Cash from Financing (Quarterly) Benchmarks
Lexicon Pharmaceuticals Inc | 239.38M |
AIM ImmunoTech Inc | 2.829M |
Perspective Therapeutics Inc | 166.33M |
Protalix BioTherapeutics Inc | 0.00 |
Armata Pharmaceuticals Inc | 34.93M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -2.947M |
Free Cash Flow | -13.86M |
Free Cash Flow Per Share (Quarterly) | -6.338 |
Free Cash Flow Yield | -1.22K% |